| Product Code: ETC7631083 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The import shipments of gram-positive bacterial infections to Ireland experienced significant growth in 2024, with top exporting countries being Germany, UK, USA, Canada, and Netherlands. The Herfindahl-Hirschman Index (HHI) indicated a shift from moderate to high concentration, reflecting a more consolidated market. The impressive Compound Annual Growth Rate (CAGR) of 21.91% from 2020 to 2024 highlights the escalating demand for these products. Moreover, the remarkable growth rate of 65.25% from 2023 to 2024 suggests a rapidly expanding market in Ireland for treatments targeting gram-positive bacterial infections.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Gram-positive Bacterial Infections Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Gram-positive Bacterial Infections Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Gram-positive Bacterial Infections Market - Industry Life Cycle |
3.4 Ireland Gram-positive Bacterial Infections Market - Porter's Five Forces |
3.5 Ireland Gram-positive Bacterial Infections Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Ireland Gram-positive Bacterial Infections Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.7 Ireland Gram-positive Bacterial Infections Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Ireland Gram-positive Bacterial Infections Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Gram-positive Bacterial Infections Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gram-positive bacterial infections in Ireland |
4.2.2 Growing awareness about the importance of appropriate antibiotic use |
4.2.3 Technological advancements in diagnostics and treatment options for gram-positive bacterial infections |
4.3 Market Restraints |
4.3.1 Rising antibiotic resistance leading to treatment challenges |
4.3.2 High cost associated with advanced treatment options |
4.3.3 Stringent regulatory requirements for antibiotic development and approval |
5 Ireland Gram-positive Bacterial Infections Market Trends |
6 Ireland Gram-positive Bacterial Infections Market, By Types |
6.1 Ireland Gram-positive Bacterial Infections Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Gram-positive Bacterial Infections Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 Ireland Gram-positive Bacterial Infections Market Revenues & Volume, By Antibiotic, 2021- 2031F |
6.1.4 Ireland Gram-positive Bacterial Infections Market Revenues & Volume, By Antifungal, 2021- 2031F |
6.1.5 Ireland Gram-positive Bacterial Infections Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Ireland Gram-positive Bacterial Infections Market, By Disease |
6.2.1 Overview and Analysis |
6.2.2 Ireland Gram-positive Bacterial Infections Market Revenues & Volume, By MRSA, 2021- 2031F |
6.2.3 Ireland Gram-positive Bacterial Infections Market Revenues & Volume, By Pneumonia, 2021- 2031F |
6.2.4 Ireland Gram-positive Bacterial Infections Market Revenues & Volume, By Sepsis, 2021- 2031F |
6.2.5 Ireland Gram-positive Bacterial Infections Market Revenues & Volume, By Sinusitis, 2021- 2031F |
6.2.6 Ireland Gram-positive Bacterial Infections Market Revenues & Volume, By Cellulitis, 2021- 2031F |
6.2.7 Ireland Gram-positive Bacterial Infections Market Revenues & Volume, By Otitis, 2021- 2031F |
6.3 Ireland Gram-positive Bacterial Infections Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Ireland Gram-positive Bacterial Infections Market Revenues & Volume, By Enteral, 2021- 2031F |
6.3.3 Ireland Gram-positive Bacterial Infections Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Ireland Gram-positive Bacterial Infections Market Revenues & Volume, By Others (Topical, Transdermal), 2021- 2031F |
6.4 Ireland Gram-positive Bacterial Infections Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Ireland Gram-positive Bacterial Infections Market Revenues & Volume, By Hospitals Pharmacies, 2021- 2031F |
6.4.3 Ireland Gram-positive Bacterial Infections Market Revenues & Volume, By Drug Stores and Retail Pharmacies, 2021- 2031F |
6.4.4 Ireland Gram-positive Bacterial Infections Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Gram-positive Bacterial Infections Market Import-Export Trade Statistics |
7.1 Ireland Gram-positive Bacterial Infections Market Export to Major Countries |
7.2 Ireland Gram-positive Bacterial Infections Market Imports from Major Countries |
8 Ireland Gram-positive Bacterial Infections Market Key Performance Indicators |
8.1 Percentage of patients receiving appropriate antibiotic therapy |
8.2 Adoption rate of innovative diagnostic technologies for gram-positive bacterial infections |
8.3 Rate of antibiotic resistance development in gram-positive bacteria |
9 Ireland Gram-positive Bacterial Infections Market - Opportunity Assessment |
9.1 Ireland Gram-positive Bacterial Infections Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Ireland Gram-positive Bacterial Infections Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.3 Ireland Gram-positive Bacterial Infections Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Ireland Gram-positive Bacterial Infections Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Gram-positive Bacterial Infections Market - Competitive Landscape |
10.1 Ireland Gram-positive Bacterial Infections Market Revenue Share, By Companies, 2024 |
10.2 Ireland Gram-positive Bacterial Infections Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |